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Interleukin-1 (IL-1) costimulation is required for efficient IL-2 synthesis and IL-2 
receptor (IG2R) expression of T cells. The molecular events leading to these 
effects are largely unknown. We utilized an IL-1-responsive and an IL-1- 
non-responsive subclone of the mouse thymoma cell line EL4 to investigate how 
IL-1 activates IL-2 gene expression.We correlated I L 2  promoter activity with the 
activity of the endogenous IL-2 gene, thereby showing the biological significance 
of our results. Our experiments provide new functional data showing that a major 
target of IL-1 mediated costimulation is the xB-like site, T cell element distal 
TCEd (GGGATTTCAC), of the IL-2 promoter. Thus, deletion or mutation of 
TCEd within a complete IL-2 promoter abrogated IL-1 costimulation in the 1L-1 
responsive EL4 subclone. Therefore. The TCEd element is functionally essential 
for the effect of IL-1.We also identified a nuclear factor (NF), IL-1 NF, that binds 
to the TCEd site after IL-1 stimulation. This factor was only present in the 
IL-1-reponsive EL4 subclone and not in the IL-1-non-responsive subclone after 
IL-1 stimulation and did not appear after phytohemagglutinin (PHA)-treatment. 
Binding of IL-1 NF to the TCEd site was competed by a typical xB oligonucleo- 
tide, suggesting that it is similar to NF-xB in its DNA-binding properties. 
However, the TCEd element was only activated by costimulation with PHA and 
IL-1 whereas a typical xB element was already activated by IL-1 alone.These data 
suggest that the biological function of the TCEd element of the IL-2 promoter 
differs from that of a canonical xB element. Our data provide new evidence that 
IL-1 acts on the IL-2 promoter by activating the TCEd element via the 
transcription factor IL-1 W. Furthermore, activation of this element requires two 
signals, delivered by IL-1 and PHA, in this way reflecting the activation 
requirement for the endogenous IL-2 gene. 
1 Introduction 
Proliferation of T lymphocytes after activation requires 
both secretion of interleukin-2 (IL-2) and expression of the 
high-affinity IL-2 receptor (IL-2R). IL-1 plays a key role in 
induction of these processes. In several experimental 
systems IL1 has been shown to synergize with mitogenic 
lectins or anti-T cell receptor (TCR) antibodies to induce 
expression of IL-2 and IL-2Ra chain genes [l-31. Recent 
data suggest that a requirement for IL-1 may reflect the 
developmental status of theT cell [4].Thus, we have shown 
that in mouse CD4-CD8- thymocytes IL-1 induces high- 
affinity IL-2R expression in synergy with IG2 [5]. In 
immature TCR-CD4-CD8- thymocytes IL- 1 provides a 
necessary signal for the induction of IL-2 gene expression 
[4,6]. In peripheral TCR+ thymocytes IL-1 can be replaced 
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by the phorbol ester PMA plus the calcium ionophore A 
23187 [6]. Whether the IL-1 signal plays an enhancing or 
obligatory role in T cell activation, however, is controver- 
sial and the mode of IL-1 action still remains unclear (for 
review see [7]). 
IL-1 can regulate the expression of the IL-2 gene on the 
transcriptional level [8,9]. Activation of the mouse IL-2 
gene is mediated through a transcriptional enhancer region 
located between the positions - 293 and - 7 relative to the 
transcriptional start site [lo] .This region is highly conserved 
between the IL-2 genes of mouse and man and contains 
multiple regulatory sequence elements (for review see 
[ll]). Numerous ubiquitous and lymphocyte-specific trans- 
acting factors have been found to bind to the IL-2 enhancer 
[lo-121. Thus, the inducible ubiquitous factors AP-1 and 
NF-xB as well as the lymphoid-specific factors Oct-2 and 
NFAT-1 have been implicated to be involved in the control 
of the IL-2 enhancer activity. In particular, NFAT-1 has 
been proposed to play a prominent role in the control of 
T lymphocyte-specific transcription of the IL-2 gene [ 131. 
Most of these factors were identified after stimulation with 
a combination of different Tcell mitogens. However, much 
less is known about the nuclear events following physiolo- 
gical activation by IG1 costimulation. Previous data de- 
scribed that the transcription factor AP-1 was induced by 
IL-1 and PMA as a costimulus [14]. In addition costimula- 
tion with IL-1 was shown to activate the NF-xB motif in the 
SV40 [15] HIV-1[16], IL-6 [17, 181 and the mouse factor B 
enhancers [19]. However, it has not been shown whether 
the xB-like element can confer IL-1 responsiveness to  the 
IL-2 promoter. 
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To investigate further the molecular events following 
IL-1-induced IL-2 secretion, we utilized two variants of the 
murine T cell lymphoma EL4, EL4 5D3 and EL4 D6/76, 
which differ in their IL-1 responsiveness 1201. EL4 5D3 
responded to IL-1 by augmentation of PMA-induced IL-2 
secretion and IL-2R expression. EL4 D6/76, however, did 
not respond to IL-1 although it expressed an IL-1R 
biochemically indistinguishable from that of EL4 5D3 cells. 
This defect in IL-1 responsiveness correlated with the 
inability to internalize receptor-bound IL-1 [20]. In addi- 
tion, we have found that IL-1 increased the transcription of 
the IG2 gene in the IL-1-responsive subclone. Therefore, 
we used these two subclones to examine the mouse IL-2 
promoter for sequence motifs which are involved in the 
activation by IL-1. 
In this report we identify the xB-like element of the IL-2 
promoter as an IL-1-responsive site. Moreover, we show 
that the xB-like T cell element distal (TCEd) of the IL-2 
promoter [21, 221 is essential for IL-1 costimulation and 
differs in its biological properties from a consensus xB 
element. In the IL-1-responsive subclone EL4 5D3 IL-1 
costimulation leads to induction of a nuclear factor (IL-1 
nuclear factor, IL-1 NF) that specifically binds to the TCEd 
element. Biological significance of this element was shown 
by correlation of IL-2 promoter activity with the activation 
of the endogenous IL-2 gene. 
pBLCAT2 (constructed and kindly given to us by U. Pes- 
sara, Boehringer Mannheim GmbH, Penzberg, FRG). 
2.4 ’kansfections 
The two EL4 subclones were grown to a density of about 
4 x lo5 cells/ml. Cells (1.4 x lo7) were transfected with 
10 pg DNA in a final volume of 1.2 ml using the DEAE 
Dextran procedure [26]. Fourty-eight hours after transfec- 
tion cells were adjusted to a density of 1 x 106 cells/ml and 
divided into four aliquots. One aliquot was used as 
uninduced control and the other aliquots were stimulated 
with IL-1 (10 U/ml), PHA (40 pg/ml) or a combination of 
PHA + IL-1, respectively. After 15 h of stimulation the 
supernatants were tested for IL-2 production [20] and the 
cell lysate was assayed for chloramphenicol acetyltransfer- 
ase (CAT) activity as described [26]. The conversion of 
[14C]chloramphenicol to its acetylated forms was quanitif- 
ied using an automatic thin-layer chromatography linear 
analyzer (Berthold, Wildbad, FRG). The protein concen- 
tration of cell extracts was measured according to Bradford 
[27] and was used to normalize CAT activity. In addition, 
the plasmid pTKCAT21A [28] was used as standard for 
transfection efficiency in each experiment. Plasmid pBLC- 
AT2 [23] was used as negative control and was uninducible 
after transfection but showed a very low basal transcrip- 
tional activity. 
2.5 Electrophoretic mobility shift assays (EMSA) 2 Materials and methods 
2.1 Cells, cell culture and 1L-2 measurement 
Selection of EL4 subclones EL4 5D3 and EL4 D6/76 was 
described by von Hoegen et al. [20]. Cells were cultured in 
RPMI 1640 containing 10% FCS and 50 pg/ml gentamycin 
at 37°C in 5% CO2. Secreted IL-2 was measured in a 
proliferation assay using an IL-2 dependent cell line [20]. 
2.2 Recombinant cytokines 
Human (hu) rIL-la was kindly provided by A. Stern and 
I? Lomedico, Hoffmann-LaRoche, Nutley, NJ.The specific 
activity was 5 x lo6 U/mg protein as determined by the 
lymphocyte activation factor assay. It was used at a 
concentration of 10 U/ml. 
The TCEd oligonucleotide 5’-gatcACCAAGAGGGATT- 
TCACCTAAATCC-3’ was labeled with [a-32P]ATP/CTP 
and the Klenow fragment [26] followed by purification on a 
12% polyacrylamide gel. Nuclear protein extracts were 
prepared from 2 x lo7 non-activated cells or from cells 
activated for 4 h, using a modified method of Dignam et al. 
[16]. In each binding reaction 5000 cpm (about 0.2 ng) of 
end-labeled probe were incubated with 5 pg protein of 
nuclear extracts in the presence of 3 pg poly (dI-dC) 
(Pharmacia LKB, Uppsala, Sweden). The binding reaction 
was performed for 20 min at 4 “C. Resulting complexes were 
analyzed by electrophoresis at room temperature on a 4% 
polyacrylamide gel at 200 V [26]. The gels were dried and 
exposed for autoradiography 
3 Results 
2.3 Plasmids 
Plasmid pIL2-293 contains the - 293 to - 7 bp region of the 
murine IL-2 promoter linked to the CAT gene in the 
plasmid pBLCAT 2 [23]. pIL2-293 was derived from the 
plasmid pIL-CAT2/1+ by digestion with BglII/BamHI to 
eliminate the tk promoter. The construction of 4 X NFAT 
(previously named 4 x Pu-bd, 21), 5 x TCEd and 
5 x TCEd + xBc.-CATconstructs was described previously 
[lo, 22, 241. The TCEd mutant TCEdM and the deletion 
mutant TCEdA were constructed by “thermal cyclic fusion 
P C R  as described [25] and their integrity was confirmed by 
sequencing [26]. 7 x NF-xB harbours seven copies of the 
xB-binding sequence 5’-GGGGAATITCC-3’ of the MHC 
class I1 invariant gene in front of the tk promoter of 
3.1 IL-1 costimulates IL-2 promoter activity and IL-2 
secretion in the IL-1-responsive subclone EL4 5D3, 
but not in the IL-1-non-responsive subclone EL4 
D6/76 
To examine molecular events of IL-1-stimulated IL-2 
secretion we used two subclones of the murine Tcell 
lymphoma EL4 that differed in their IL-1 responsiveness. 
Both subclones were CD3+ CD4+ CD8- and expressed 
identical numbers of surface IL-1R [20]. Subclone EL4 5D3 
reacted to IL-1 with enhanced IL-2 secretion and IL-2R 
expression whereas the subclone EL4 D6/76 did not. The 
defect of EL4 D6/76 cells correlated with the inability of 
these cells to internalize receptor-bound IL-1 [20]. 
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been shown whether the xB-like element within the IL-2 
promoter plays a functional role for IL-1 costimulation. 
Therefore, our experiments focused on the xB-like site, 
TCEd, within the IL-2 promoter. A construct containing a 
pentamer of TCEd (5 x TCEd, 10) fused to the CATgene 
was transfected into EL4 5D3 cells. In parallel the pIL2-293 
plasmid (see Fig. 1) was used as a positive control. Since 
NFAT-1 binding was shown to  be stimulated by PHA [ 13, 
241 a 4 x NFAT-CAT construct [24] was used. Transfected 
cells were stimulated by IL-1, PHA or PHA + IL-1. The 
constitutively active plasmid pTKCAT21A [28] was used as 
control for transfection efficiency and was equally 
expressed in stimulated or unstimulated cells. The negative 
control, pBLCAT2 [23], was inactive in stimulated or 
unstimulated cells. All transfected cells responded to IL-1 
with increased IL-2 production irrespective of the plasmid 
used. This shows that the plasmids did not interfere with 
induction of the endogenous IL-2 gene and that the 
induction conditions were appropriate. 
Fig. 2 shows that optimal activation of the plasmid pIL2- 
293 was only seen with a combination of PHA and IL-1 
[Stimulation index (SI) = (PHA+ IL-1)RHA = 4.01 but 
not with PHA or IL-1 alone.The same synergy was seen on 
the level of IL-2 secretion. CATactivity of the 5 X TCEd 
construct was only induced by a combination of PHA and 
IL-1 (SI = 3.4). In contrast, the 4 x NFATconstruct was 
activated by PHA alone, but did not show any response to 
IL-1 costimulation. Taken together, our experiments 
demonstrate for the first time that the TCEd element is an 
IL-1-responsive site of the IL-2 promoter and confers IL-1 
inducibility to another promoter. 
A. EL4 5D3 
8 
6 
t 4  
* 2  
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B. EL4 D6i76 
Figure 1. EL4 subclone EL4 5D3 and not subclone EL4 D6/76 
reacts to IL-1 with enhanced IL-2 secretion and IL-2 promoter 
activity. EL4 5D3 (1A) and EL4 D6/76 (1B) cells were transfected 
with an IL-2 promoter-CAT construct (pIL2-293) containing a 
DNA fragment from position -293 to -7  relative to the 
transcription start site. Cells were stimulated for 15 h with 
increasing concentrations of PHA alone (V), or PHA and IL-l(O). 
CAT activity was measured as described [23] and the amount of 
IL-2 secreted into the supernatant was determined in a prolifera- 
tion assay in comparison to an IL-2 standard. Unstimulated cells or 
cells stimulated with IL-1 alone did not produce I L 2  and the IL-2 
promoter-CAT construct was not activated. One representative 
experiment of six performed is shown. 
Both subclones were transfected with the plasmid pIL2-293 
that contained 5’ sequences (from position -293 to - 7  
relative to the start site of transcription) of the murine IL-2 
promoter linked to the CAT reporter gene. Fourty-eight 
hours after transfection the cells were stimulated for 16 h 
with increasing amounts of PHA alone, or PHA in 
combination with IL-1. CAT activity was measured in the 
cell lysates and secreted IL-2 was measured in the super- 
natants. PHA was chosen because in contrast to the PKC 
activator PMA it mimics activation via the T cell receptor 
complex [29]. In subclone EL4 5D3 the transfected IL-2 
promoter construct showed synergistic stimulation with 
PHA and LL-1 (Fig. 1A). The same effect was observed for 
endogenous IL-2 expression, measured as secreted IL-2. As 
expected, subclone EL4 D6/76 did not react to IL-1 
costimulation (Fig. 1B). Neither IL-2 secretion nor IL-2 
promoter activation were found to be enhanced.These data 
confirm our previous results [20]. In addition, they show 
that IL-1 affects the activity of the IL-2 promoter and that it 
is able to costimulate with PHA. Therefore, the EL4 
subclones are particularly suitable to study the molecular 
events leading to the induction of IL-2 promoter activity 
following IL- 1 costimulation. 
3.2 The xB-like TCEd, but not the NFAT-1-binding site 
of the IL-2 promoter was activated by IL-1 
costimulation 
In previous experiments IL-1 was shown to activate NF-xB 
elements of different genes 114-181. However. it has not 
plasmid: plL2-293 5xTCEd 4xNFAT 
SI CAT: 4.0 3.4 0.8 
SI IL-2: 6.5 8.0 7.0 
Figure 2. The NF-xB-like element TCEd of the IL-2 promoter is a 
site for IL-1 costimulation. Plasmid pIL2-293 contains the minimal 
promoter element of the murine IL-2 gene spanning the nucleo- 
tides from - 293 to - 7 relative to the transcription start site [lo]. 
5 X TCEd contains five copies of the xB-like element TCEd [lo, 
191 and 4 x NFATcontains four copies of the distal NFAT-1 binding 
site (Pu-bd) in front of the tk promoter in pBLCAT2 [21], 
respectively.These plasmids and the control plasmids pTKCAT2lA 
and pBLCAT2 were transfected into EL4 5D3 cells. Cells were 
either left unstimulated (-) or were stimulated with PHA 
(40 pg/ml), IL-1 (10 Ulml) or a combination of PHA and IL-1. 
CAT activity of the various transfected cells is shown as % 
acetylation. The positive control pTKCAT2lA was constitutively 
expressed and % acetylation determined was: 68% (-), 72% 
(IL-l), 75% (PHA), 73% (PHA + IL-1). The negative control 
pBLCAT2 was not inducible and exhibited a low basal transcrip- 
tion activity of less than 2% acetylation. SI for CATactivity and 
IL-2 secretion were calculated as (PHA + IL-1)PHA. One 
reoresentative exDeriment out of four Derformed is shown. 
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3.3 The TCEd element of the IL-2 promoter is essential 
for IL-1 action 
To investigate the importance of theTCEd element for IL-1 
costimulation of the whole IL-2 promoter a site specific 
mutant was constructed by PCR. The clustered mutation 
(S'GGG+TIT) of the xB-like TCEd element, TCEdM, 
was selected because identical base substitutions had been 
shown to abolish the specific binding of NF-xB to a 
consensus NF-xB site [30]. In addition, a deletion mutant, 
TCEdA, lacking the TCEd element (from - 207 to - 195) 
was constructed. EL4 5D3 cells were transfected with these 
constructs and stimulated with PHA, IL-1 and PHA + 
IL-1. CATactivities and IL-2 secreted into the supernatant 
were measured. As shown in Fig. 3 both the mutation 
(TCEdM) and the deletion (TCEdA) of theTCEd element 
completely abolished responsiveness of the IL-2 promoter 
to IL-1 costimulation. Therefore, the TCEd element of the 
IL-2 promoter is functionally essential for the action of 
IL-1. 
w t  -gaGGGATTTCACct- 
n -gaTTTATTTCACct- 





plasmld: plL2-293 TCEd M 
SI CAT: 7.4 1 .o 




Figure 3. Induction of the IL-2 promoter by IL-1 costimulation is 
abrogated by mutation or deletion of the TCEd element. A) 
Sequences of the NF-xB-like element TCEd of the IL-2 promoter 
and sequences of the mutated (TCEdM) and deleted (TCEdA) 
elements are shown. B) EL4 5D3 cells were transfected with 
plasmids pIL2-293,TCEdM and TCEdA. Stimulation was done as 
described in Fig. 2. Controls were transfected in parallel and YO 
acetylation obtained was 56% (-), 54% (IL-l), 58% (PHA), 62% 
(PHA + IL-1) for pTKCAT21A and 0.3% (-), 0.2% (IL-1), 0.3% 
(PHA), 0.3% (PHA + IL-1) for pBLCAT2. SI were calculated as 
described in Fig. 2. One representative experiment out of six 
performed is shown. 
3.4 IL-1 NF, a specific IL-1-inducible nuclear factor, 
binds to the TCEd element 
The results of transfection studies suggest that IL-1 induci- 
ble nuclear factors may bind to and control the activity of 
theTCEd element.To address this question we investigated 
the IL-1-responsive subclone EL4 5D3 and the IL-1- 
non-responsive subclone EL4 D6/76 for IL-1-inducible 
nuclear proteins that might bind to the TCEd element in 
EMSA. 
A B C 
EL4 5D3 EL4D6n6 TCEdM IPKB 
- +  . +  I - P+I P I - P+I P 
11-1 NF b 
TCEd b 
Figure 4. Binding of the IL-1-inducible factor IL-1 NF from EL4 
5D3 cells to theTCEd element. EL4 5D3 cells (A) and EL4 D6/76 
cells (B) were left untreated (-), or stimulated for 4 h with IL-1 (I), 
PHA (P), and PHA + IL-1 (P + I). Nuclear extracts were prepared 
as described by [13] and incubated with a labeled oligonucleotide 
containing the TCEd site and analyzed in electrophoretic mobility 
shift assays. For competition (C) the Ig-xB (5'-GGGACTITC- 
C-3') and TCEdM (5'-TITATITCAC-3') oligonucleotides were 
used, as indicated. Arrowheads indicate the positions of the free 
probe and the IL-1 inducible DNA-protein complex. 
Both subclones were activated with IL-1, PHA or PHA + 
IL-1 for 4 h and nuclear extracts were prepared and assayed 
in EMSA. Fig. 4A shows that in extracts of EL4 5D3 cells 
three individual protein factors bound to theTCEd element 
after stimulating the cells with PHA and IL-1. We named 
the most prominent factor IL-1 NF. IL-1 NF was induced by 
stimulation with IL-1 alone. The two faster-migrating 
protein complexes were already present in unstimulated 
cells but were up-regulated upon stimulation with PHA. 
IL-1 did not induce generation of IL-1 NF in EL4 D6/76 
cells, correlating with their inability to react to IL-1 
(Fig. 4B). In these cells, like in EL4 5D3 cells, PHA 
stimulation enhanced binding of the two faster migrating 
protein complexes. Induction of these two complexes was 
not sufficient for transcriptional activation of TCEd but 
might reflect a mode of costimulation via PHA. 
Binding of IL-1 NF and the faster-migrating proteins was 
competetively inhibited by an excess of NF-xB consensus 
sequence from the Ig x enhancer (Fig. 4C) suggesting that 
these proteins are either identical or similar in their 
DNA-binding properties to NF-xB. The mutated TCEd 
site, TCEdM, (see Fig. 3) was unable to compete for 
binding. This shows that mutation of TCEd abolishes 
binding of these proteins. 
3.5 Activation of TCEd by IL-1 is functionally different 
from activation of a consensus NF-xB element 
The NF-xB consensus sequence competed for binding of 
IL-1 NF to the TCEd element. NF-xB is an ubiquitous 
factor and NF-xB elements are inducible in various cell 
types. In contrast, the TCEd motif was shown to be a 
T cell-specific enhancer element [21, 221. We wanted to 
investigate whether the sequence differences between the 
NF-xB and TCEd elements had consequences on IL-1 
responsiveness of the TCEd element. Therefore, EL4 5D3 
cells were transfected with the constructs 5 x TCEd, 
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Utilizing IL-1-responsive and IL-1-non-responsive sub- 
clones of the murine thymoma EL4 [20] we have previously 
shown that IL-1 costimulates IL-2 gene expression by 
enhancing the activity of the IL-2 promoter [8]. In this 
report we further investigated IL-1 responsive elements of 
the IL-2 promoter. We identified the xB-like element, 
TCEd, as a major target of IL-1 costimulation. xB-like 
elements were shown to be involved in the activation of 
several other genes by IL-1[15-19].We show here that IL-1 
activates IL-2 production through the xB-like element 
TCEd. Furthermore, we demonstrate that IL-1 costimula- 
tion of IL-2 promoter activity in the IL-1 responsive EL4 
subclone was abolished by mutation or deletion of the 
TCEd element. Therefore, we provide functional evidence 
that theTCEd element is essential for the IL-1 effects on the 
IL-2 promoter. By comparing the non-responsive with the 
IL-1-responsive EL4 variant we detected an IL-1-inducible 
nuclear factor, IL-1 NF. DNA binding of IL-1 NF was 
induced by IL-1 only in the responsive subclone. According 
to its electrophoretic mobility, IL-1 NF differed from two 
other factors that were found to be upregulated by PHA 
stimulation. The DNA binding properties of IL-1 NF are 
similar or identical to NF-xB. It was shown that purified 
NF-xB binds to the TCEd element [22,31]. In our experi- 
ments a xB consensus oligonucleotide competed for bind- 
ing of IL-1 NF to the TCEd site. However, we present 
functional data that IL-1 NF is likely to be different from 
NF-xB.When theTCEd motif was converted to a canonical 
NF-xB motif (TCEd + xBc.) its functional activity was also 
changed. In contrast to the activation of theTCEd element 
Ll alone was sufficient for activation of the TCEd + xBc. 
element. This finding is in agreement with the report of 
Kang et al. [32] who showed that for the Ig-xB site CAT 
activity could be stimulated by APC alone (possibly by 
secreting IL-1). IL-2 xB activation, however, required both 
antigen and APC [32]. In addition, Briegel et al. showed 
that theTCEd + xBc. construct was inducible in non-T cells 
[22]. Nevertheless, IL-1 NF may be composed of members 
of the NF-xB family. This family comprises numerous 
structurally related factors including the c- and v-re1 
oncogene products and Drosophila dorsal gene products 
[33-361. 
Our findings are in agreement with the report by Novak et 
al. [9] correlating IL-1 costimulation with augmented levels 
of two TCEd binding factors. In their experiments PMA 
alone induced binding of these two NF-xB-like factors in 
EL4 cells. The binding activities especially of the slower- 
migrating factor which comprise IL-1 NF were further 
enhanced by IL-1. They also showed that IL-1 alone was 
able to up-regulate IL-1 NF. We also found that activation 
with PMA, in contrast to PHA stimulation gives only 
suboptimal IL-1 NF induction. Addition of IL-1, however, 
upregulated binding activity of IL-1 NF preferentially (data 
not shown). The striking negative effect of mutation or 
deletion of theTCEd motif on IL-1 mediated costimulation 
of the IL-2 promoter provides new functional data that the 
TCEd element is essential for IL-1 effects. 
A KB consensus GGGRNTYYCC 
KB GGG A A T T T  C C 







plasmid: 5xTCEd ~xTCE~+KBC. 7xNF-id 
lL-2[U/ml]: 0 0 12 0 0 8 0 0 11 
Figure5 The xB-like site TCEd from the IL-2 promoter is 
functionally distinct from a consensus xB site. A) Sequences of 
NF-xB motifs present in the plasmids 5 X TCEd, 
5 x TCEd + xBc. and 7 x NF-xB. B) EL4 5D3 cells were trans- 
' fected with 5 x TCEd, 5 x TCEd + xBc., 7 x NF-xB and control 
plasmids. They were left unstimulated or were stimulated with 
PMA (2 ng/ml) or IL-l(l0 U/ml). CATactivity was measured as % 
acetylation. Secreted I L 2  was measured as described in Sect. 2.1. 
The values for the positive control pTKCAT21A and the negative 
control pBLCAT2 were, respectively: 62 and 0.5% (-), 58 and 
0.4% (IL-1), 66 and 0.4% (PMA). One representative experiment 
of six performed is shown. 
7 x NF-xB and with a construct containing aTCEd core 
which was converted to a consensus NF-xB sequence, 
TCEd + xBc. (xB core; see Fig. 5A). Cells were treated 
with IL-1 or PMA and CATactivity and IL-2 secretion were 
determined. PMA stimulation was used as a control for 
mitogen-dependent increase in CAT activity of the three 
constructs, as in EL4 5D3 cells PMA alone is sufficient to 
activate IL-2 secretion.The TCEd element was not induced 
by IL-1, as expected, but by PMA alone. This activation 
pattern correlated well with the activation of the endoge- 
nous IL-2 gene (Fig. S).The mutation of TCEd to aTCEd + 
xBc. sequence had a strong effect on the IL-1-induced 
enhancer activity, as IL-1 was sufficient for activation. 
Activation with IL-1 was even stronger (6-fold induction) 
than activation with PMA (4.3-fold induction). The 
7 x NF-xB construct exhibited the same effect.This finding 
was in striking contrast to the activation of the endogenous 
IL-2 gene. The endogenous IL-2 gene was not induced with 
IL-1 alone, but PMA was sufficient to activate IG2 
secretion (about 12 U/ml). 
Therefore, TCEd is a T cell-specific element [22] whose 
activity is induced by IL-1 costimulation. It differs in its 
biological properties from the non-tissue-specific consen- 
sus NF-xB element. 
4 Discussion 
The initiation of T cell activities in immune responses 
requires costimulation by the cytokine IL-1. Relatively 
little is known about the mode of IL-1 costimulation. 
The role of AP-1 in IL-1 costimulation of the IL-2 promoter 
is controversial. Muegge et al. [37] showed that in the 
mouse thymoma LBRh4-331A5 IL-1 induced transcription 
of c-jun, a component of AP-1. These authors further 
showed that deletion of a fragment from - 218 to - 176 of 
the IL-2 promoter abrogated the effect of IL-1. Therefore, 
1480 
they concluded that a potential AF-1-binding site located 
around position - 180 of the IL-2 promoter was responsible 
for this effect. However, they also deleted the essential IL-1 
responsive TCEd element, thereby abrogating the IL-1 
effect. Furthermore, Muegge et al. did not show functional 
data that the AP-1 element at - 180 of the IL-2 promoter 
was the IL-1 responsive site, because they used the 
collagenase AP-1 sequence in their transfection experi- 
ments which differs from the AP-1 site at - 180.Therefore, 
there is no convincing functional data that the A€-1 
element at - 180 is an IL-1-responsive element. Several 
other studies have shown that deletion of this element has 
no effect on inducibility of the IL-2 promoter [lo, 12, 321. 
Leonard et al. reported that antibodies against c-jun and 
c-fos failed to react with complexes formed at this site and 
neither the IL-2 AP-1 (at - 150) nor the collagenase AP-1 
oligonucleotides could compete with the complexes [29]. 
Rothenberg et al. showed that IL-1 costimulation resulted 
in enhanced activity of an AP-1 like factor that binds to the 
proximal AP-1 site around position - 150 of the IL-2 
promoter [9]. However, Muegge et al. have shown that 
deletion from - 169 to - 101 did not affect IL-1 respon- 
siveness. In our system mutation of the proximal Ap-1 site 
within the IL-2 promoter did also not affect IL-1 activity 
(data not shown). Taken together, these data indicate that 
A€-1 does not seem to play a major role in IL-1 costimu- 
lation of the IL-2 promoter. 
K. Stricker, E. Serfling, F! H. Krammer and W. Falk Eur. J. Immunol. 1993. 23: 1475-1480 
Mizel proposed a model of IL-1 activity [7] in which IL-1 
initiates IL-2 and IL-2Ra synthesis and expression. Con- 
comitant increased expression of the IL-1R then renders 
the cells fully responsive to IL-1. A common transcription 
factor was described to be involved in the regulated 
expression of IL-2 and IL-2 R a  genes [38] that both contain 
NF-xB-like elements. The transcription factor bound to 
TCEd and to the IL-2Ra xB-like site but displayed 
properties different from NF-xB [38]. It is likely that this 
factor is related to or identical to  IL-1 NF. Therefore, IL-1 
may regulate both IL-2 and IL-2Ra expression through 
induction of IL-1 W. Further studies to investigate this 
question are in progress. 
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